ArticleClinical cancer research : an official journal of the American Association for Cancer Research2015

Phase I Study of Vorinostat as a Radiation Sensitizer with 131I-Metaiodobenzylguanidine (131I-MIBG) for Patients with Relapsed or Refractory Neuroblastoma.

Steven G DuBois et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.